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One troublesome part of the risk assessment
of chemical mixtures concerns the need for
quantitative methods to support regulatory
decisions, particularly when most of the
desired information is missing yet resources
and time for obtaining that information are
insufﬁcient. For the dose–response assessment
step, the desired information includes the
dependence of toxicity on the total mixture
dose as well as its component chemical pro-
portions, the magnitude and nature of toxico-
logical interactions, and (nearly always) the
methods for extrapolating from animal studies
to human dose response in terms of interac-
tions or of the whole-mixture toxicity. A few
regulatory agencies have developed formulas
that help identify the nature or degree of pos-
sible public health concern for specific mix-
ture exposures. Because key information is
usually absent for those mixtures, the formulas
require several default steps or parameters.
Thus we have the dilemma: a) formulas are
developed that usually rely on simpliﬁcations
and defaults; b) data are usually lacking for
judging the accuracy of these formulas; c) regu-
latory agencies such as the U.S. Environmental
Protection Agency (U.S. EPA) are required to
be clear about the accuracy and uncertainties
of their assessment methods.
Because the usual comparison of predicted
to observed is rarely possible, some other
approaches are needed for evaluating the qual-
ity of these formulas. It must be noted that
these evaluations of plausibility, often called
“groundtruthing,” should also be performed
for any regulatory approach. Even when the
desired data are available for predicted-
observed comparisons, they will represent only
a snapshot of a generally complicated setting,
often involving a virtually inﬁnite number of
combinations of factors. Evaluations of the risk
formula based on fundamental properties and
less dependent on a particular data set are then
helpful and may in fact be more relevant to the
adoption of a risk formula for general use.
Dose–response assessment methods for
mixtures can be evaluated for plausibility, if
not accuracy, by judging consistency with
several desirable characteristics. This
approach is somewhat similar to the judg-
ments that are made of conﬁdence in the risk
values of the U.S. EPA’s Integrated Risk
Information System (IRIS), the U.S. EPA
online database of risk-based exposure limits
and measures of toxic potency (1). The U.S.
EPA reference dose (RfD) is an estimate
(with uncertainty spanning perhaps an order
of magnitude) of a daily oral exposure to the
human population (including sensitive sub-
groups) likely to be without an appreciable
risk of deleterious effects during a lifetime. It
can be derived from a no observed adverse
effect level (NOAEL), lowest observed
adverse effect level, or benchmark dose, with
uncertainty factors generally applied to
reflect limitations of the data. The RfD is
generally used in the U.S. EPA’s noncancer
health assessments. For example, the RfD for
a single chemical is judged to be a bounding
value of high confidence if the supporting
data sets are consistent, require minimal
extrapolation to the case of human chronic
exposure, and represent the main toxic
effects of concern. We examine in this article
some ideas used or proposed by the U.S.
EPA to evaluate simple risk assessment for-
mulas. In particular, we demonstrate how
default-based risk assessment formulas for
chemical mixtures can be judged for plausi-
bility and usefulness in a health-protective
regulatory context. The purpose of this arti-
cle is not to derive conclusions on the accu-
racy of any of these formulas but to use them
only to clarify the difficulty in evaluating
such formulas. First, general concepts are
presented related to toxicologic interaction
and mixture toxicity. Then the noninterac-
tive hazard index (HI), the sum of the hazard
quotients (HQs) of component chemicals in
a mixture, is discussed, followed by two ver-
sions of an interaction-based HI. Finally, we
propose and demonstrate steps for evaluating
risk formulas when direct comparison with
actual risk measures is not feasible.
U.S. EPA Component Methods
for Mixture Risk Assessment
The focus of this article is on component-
based dose–response methods for use in mix-
ture risk assessment. For this article, we
deﬁne a mixture to be the set of environmen-
tal chemicals that jointly contribute to the
same toxicity in the same exposed population.
The chemicals need not cause the same toxic-
ity from individual exposure but must have
joint influence from their combined expo-
sure. For example, they could cause different
effects during single-chemical exposure but
inﬂuence each other’s metabolism, and hence
each other’s internal dose, during simultane-
ous exposure. The chemicals need not be spa-
tially or temporally coincident as long as they
jointly play a role in toxic effects in the
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exposed individual (2). This deﬁnition makes
an assumption, however, that there is indeed
some time-based overlap of exposure or toxic-
ity. Examples of overlapping exposure include
the internal human doses reaching the same
sites of metabolism or target tissues, or simply
the co-occurrence of the chemicals in the
same physiological location (e.g., two
ingested chemicals combining chemically
under acidic conditions in the stomach to
form a new chemical). Overlapping toxic
effects may be caused by persistence of effects
beyond the exposure time, so there is joint
toxicity in spite of no overlap of the external
exposures. An example of toxicity overlap is
the classic description of carcinogenic initia-
tion and promotion. Chemicals that have no
overlap and no commonality of metabolic
pathways or toxic effects would usually be
treated separately (3).
Component-based methods for joint dose
response require consideration of toxicologic
interactions among the pairs and higher com-
binations of the mixture component chemi-
cals. Nearly all published toxicologic
interaction studies involve only chemical pairs
(4). Consequently, the two U.S. EPA data-
bases that address toxicologic interactions
include only studies on two-chemical combi-
nations (5,6), and the interaction-based risk
approaches in this article require information
only on two-chemical interactions.
Toxicologic interaction has no intrinsic
characteristic or measure that points toward a
unique definition. Instead, interactions are
determined by departure from what would be
expected under normal circumstances, i.e., if
no interaction occurred. Unfortunately, there
is no consensus on what deﬁnes “no interac-
tion” (7–9). The advantage to a regulatory
agency is they can then choose a deﬁnition to
facilitate the assessment of mixture risk. Dose
addition has an easy interpretation, is the
original regulatory approach ﬁrst proposed in
1963 by the Association of Governmental
and Industrial Hygienists (10), and has been
used by the U.S. EPA more than any other
component-based mixture risk approach, pri-
marily in the assessment of health risk at haz-
ardous waste sites (11). Consequently, we
propose dose addition as the preferred no-
interaction model for chemicals that con-
tribute to a common toxic effect, and deﬁne
toxicologic interactions as deviations from
dose addition. Synergism is then indicated by
data showing a greater response than that pre-
dicted by dose addition. When adequate
interaction information is not available, the
U.S. EPA usually applies dose addition as a
no-interaction default approach.
Biologically based mathematical models of
the exposure-joint toxicity relationship are the
preferred basis of quantitative risk assessment,
but they are extremely rare when compared
with the large number of potential chemical
combinations. Physiologically based pharma-
cokinetic models are by far the most frequent
model type, but even those have been devel-
oped for only a few combinations, mostly
chemical pairs (4,12,13). Most of the litera-
ture on toxicologic interactions present quali-
tative discussions of observed effects and a
classiﬁcation of the joint toxicity as either con-
sistent with additivity (usually dose or risk
additivity), or suggestive of greater or less than
additivity, that we will call synergism or antag-
onism, respectively. These judgmental interac-
tion classiﬁcations, however vague or unevenly
described, can be useful. Two benefits from
making judgments of interaction (and perhaps
more) are to indicate the consequences of
using a default no-interaction regulatory
model and to facilitate investigations of a pos-
sible mode of action and mode of interaction
that would explain the joint toxic effects.
This article focuses on the first benefit.
The second motivation seems to require
more understanding of basic principles of
toxicologic interaction and the degree to
which certain modes of action are unique in
causing observed toxicity. We are not con-
vinced that those principles have been ade-
quately identified for general application to
mixture risk and so leave that discussion to
future work.
Noninteractive hazard index. The U.S.
EPA has concerns for thousands of chemicals
but has regulations only on hundreds of
them. In addition to the time it takes to draft
risk-based standards, there is the constraint
of lack of key information on which to base
those risk estimates. The operating procedure
is then to develop default methods that
would be used when the desired data are
missing. For mixtures, the U.S. EPA has two
default approaches. If the mixture’s compo-
nent chemicals cause different effects with no
suggestion of toxicologic interaction, separate
risk assessments are performed. If the chemi-
cals cause the same effect, or at least damage
the same target organ, then the default com-
ponent-based approach is dose addition,
most often implemented using the dimen-
sionless HI (3,11), which is defined for oral
exposures by
, [1]
where
Ej = exposure level of chemical j,
RfDj = RfD of chemical j, and
HQj = HQ for chemical j (dimensionless).
Note that the exposure must represent the
same quantity as the RfD: if the RfD repre-
sents a lifetime daily ingested dose in units of
milligrams per kilogram per day, then E must
also represent the lifetime daily ingested dose
and be in the same units. The HI is consis-
tent with dose addition as long as 1/RfD is
viewed as a rough estimate of toxic potency.
Under dose addition, each component chem-
ical behaves as a dilution or concentration of
the other components, so except for dose scal-
ing, the dose–response curves are identical.
The mixture dose is then the sum of the com-
ponent doses once each is scaled for its
potency. The HI formula is also consistent
with Berenbaum’s zero interaction equation
(14), where his equitoxic or isoeffective dose,
e.g., a single chemical’s ED10, in the denomi-
nator is replaced by the RfD. (EDx = effective
dose associated with x% response rate in the
exposed group.)
It must be noted that the HI is a very
rough application of dose addition. In both
of the above analogies, the RfDs are viewed
as equitoxic doses. In the best of circum-
stances, they are estimates of toxicity thresh-
olds—maximum doses with no response.
The actual situation is more complex. For
example, an RfD may be the ratio of an
experimental dose with NOAEL divided by
the product of several uncertainty factors
that depend on the underlying toxicity data-
base. Whereas the uncertainty factors are
usually conservative, i.e., overestimates of
equitoxic scaling factors that make the RfD
smaller than it should be, the NOAEL is
anticonservative, i.e., it overestimates the
true threshold dose, making the RfD higher
than it should be. Consequently, the ratio of
these two values, with unknown counterbal-
ancing errors, is difﬁcult to evaluate. Because
the HI involves several RfDs with different
NOAELs and uncertainty factors (UFs), the
bias in the HI is even more difﬁcult to char-
acterize. For the remainder of this article, the
HI will be assumed to be based on RfDs
equally uncertain and equally biased, so the
evaluation of modifications of this formula
can be judged on their conceptual properties.
HQ is a component dose scaled by the
inverse of its RfD. For the risk characteriza-
tion of a single chemical, the decision point
is HQ = 1, i.e., when a chemical exposure is
at its RfD. Any smaller exposures are consid-
ered to pose no significant health risk. For
the mixture, the corresponding decision
point is HI = 1. One interpretation, HI = 1,
represents the situation where the mixture is
at its RfD. The complication is that the mix-
ture RfD is actually an infinite number of
component combinations, not a single point.
For example, with a mixture of only two
chemicals, one can draw the dose addition
isobole for a response of 1%. If the RfD were
deﬁned in terms of a very small response rate
(1%, for example) of a nonadverse effect
(perhaps a precursor to toxicity), then the
1% isobole would be the set of all mixture
HI =
E
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RfDs, two-chemical dose combinations
producing the 1% mixture response.
The HI in Equation 1 is constrained to
combinations of chemicals that are toxico-
logically similar. That similarity is not pre-
cisely defined, and the evidence can range
from identical cellular mechanisms to a
judgment of rough similarity in the impact
on the same target organ. Usually it is
viewed as a neutral approach for addressing
potential joint toxicity because it does not
reﬂect synergism or antagonism.
Interaction-based hazard index. In the
original U.S. EPA mixture guidelines (15)
and the recent supplement (3), the recom-
mendation is to use interaction data when
available. The practical approach adopted by
the U.S. EPA is to modify the HI according
to the available evidence on pairwise interac-
tions. In the ﬁrst approach (16), a judgmental
weight of evidence (WOE) evaluation of the
interaction studies was converted into a
numerical score, then inserted into a formula
multiplied by the HI. The formula for that
interaction-based HI is
, [2]
where UFI is an uncertainty factor for
interactions with the default value of 10.
The exponent, WOEN, is a normalized
value, further deﬁned by
, [3]
where the denominator is the maximum
value of the numerator function, i.e., the
value if the WOE data were perfect. These
two right-hand functions are
[4]
, [5]
where
n = the number of chemicals in the
mixture,
j, k = indices for the pair of chemicals
whose interaction is being considered, and 
Bjk = the interaction WOE score for
influence of chemical j on the toxicity of
chemical k.
The WOE score is negative for less-than-
additive interactions, and positive for
greater-than-additive interactions. B is the
weight-of-evidence score reflecting a judg-
ment of the potential for toxicologic interac-
tion in humans based on observed
interactions in toxicologic studies. The range
of B is [–1,1]. The value of B = 0 is used for
those chemicals where pairwise exposures are
shown to be dose additive or are presumed
so because of inadequate interaction data. It
should be noted that the UF in this formula
serves a different purpose than the UF in the
RfD formula. For the RfD, the UF errs on
the side of conservatism when data are weak,
i.e., the UF is large, causing a reduction in
the estimated safe dose. With interactions,
however, the UF reflects the quality of the
evidence for an interaction. With weak evi-
dence, the UF reduces the influence of the
reported interactions, so the formula
approaches the noninteractive (dose-addi-
tive) HI in Equation 1. Weak data do not
make the formula more conservative or
protective.
In 1999 (2), the U.S. EPA published a
reﬁned formula for an interaction-based HI.
Equation 2 was devised as a simple way to
alter the standard HI based on evidence that
toxicologic interactions were plausible.
Certainly, the simplest modiﬁcation involves
one additional factor. Even though the modi-
fying factor is derived from several pairwise
evaluations, the final formula is easy to fol-
low. This simpliﬁcation, however, was one of
the key issues motivating the reﬁned formula:
use of a single multiplicative factor with the
additive formula to account for the composite
influence of all pairwise interactions. The
refined formula differs by having an adjust-
ment factor for each HQ. This updated ver-
sion then represents toxicologic interaction by
a change in each component’s toxic potency.
The revised interaction HI is (2)
,[6]
where
Mjk = magnitude of the interaction,
Bjk = the WOE score for the interaction
of chemicals j affecting toxicity of chemical k
(see below for more explanation),
f and g, the two exposure-dependent func-
tions, are deﬁned as
[7]
[8]
The function f is a normalizing function that
ensures the modifying summation is numeri-
cally constrained. For example, if all chemical
pairs are dose additive, f makes Equation 6
equal to the dose-additive HI in Equation 1.
The function g is based on the concept that
the interactive influence should be maximal
when both chemicals are equitoxic. This
means as one chemical dominates the mix-
ture, the interactive inﬂuence diminishes, so
the mixture toxicity becomes that of the
dominant chemical (2).
Most of the toxicologic interaction studies
describe the interaction in terms of altered
pharmacokinetics of one or more of the mix-
ture chemicals, where the change in toxicity is
caused by changes in the active chemical’s
concentration in the target tissue (3,17).
Equation 6 was largely motivated by this
interaction concept, and so presents each pair-
wise interaction as an incremental alteration in
the toxicity of each chemical (i.e., effectively
changing its HQ).
A second motivation for Equation 6 was
the desire to include the interaction magni-
tude (M; the ratio of the observed EDx to the
EDx predicted from dose addition), a quan-
tity missing from Equation 2. There is no
commonly used deﬁnition of M. Interactions
are often described qualitatively in terms of
altered response, such as an increase in sever-
ity of the histopathology, or quantitatively in
terms of a change in the numbers of animals
affected. In the U.S. EPA mixture guidance
(3), the M for Equation 6 is preferably given
as the proportional change in ED. For exam-
ple, the isobologram analysis of a mixture
response uses this concept by displaying the
measured isoeffective dose combinations rel-
ative to the predicted line of dose additivity
(18). As a second example, Mehendale (19)
used x-fold changes in the lethal dose with
50% response rate to show a range of poten-
tiation from 1.6- to 67-fold. A 67-fold dose
reduction can be applied to any selected
response rate, whether an ED01 or an ED90.
The corresponding increase in response,
however, is not as useful a measure of poten-
tiation magnitude. For example, the response
at an ED01 (1%) can be potentiated to
increase up to 100-fold, but the response at
an ED20 can only increase 5-fold. The M is
assumed to be roughly constant over the dose
range of interest, varying mostly because of
changes in component proportions not total
dose. Because most measures of toxic
response (e.g., enzyme activity, relative
increase in organ weight, fraction of animals
responding) are bounded, an M deﬁned by a
change in measured response is not likely to
be constant. In the application of Equation
6, the M is recommended to represent the
change in effective dose.
The binary WOE classification and its
score, B, are almost identical to their coun-
terparts in the 1992 formula of Equation 2.
In both versions, the value of B is negative
for antagonism and positive for synergism,
with –1 and 1 indicating the strongest
evidence for each interaction, respectively.
g
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scores, respectively, for Equation 6. The
WOE decision approach for Equation 2
(Table 3) has more steps but is similar to that
for Equation 6 in that the evidence is judged
according to the extent of extrapolation or
inference required. The Agency for Toxic
Substances and Disease Registry discusses
this WOE scheme in detail in its mixture risk
guidance (20). In both Equations 2 and 6,
the WOE judgment gives a score closer to
zero as the quality or relevance of the interac-
tion information diminishes (or evidence for
dose addition strengthens). Note the U.S.
EPA scores are not symmetric. To err on the
side of increased protection, the U.S. EPA
approach requires stronger evidence for
antagonism before allowing a relaxation of
expected toxicity.
During the discussion of the two formulas
(Equations 2, 6), we evaluated their numerical
values for a few plausible simpliﬁed conditions
and discovered a dramatic difference. For the
conditions involving perfect evidence for syn-
ergy, i.e., where B = 1, the value of Equation 2
became constant, regardless of changes in mix-
ture composition (Figure 1). This is easily seen
in the formula for the exponent, WOEN
(Equation 3). When all the Bjk= 1, the numer-
ator (Equation 4) equals the denominator
(Equation 5) regardless of the values for the
component exposure levels.
This unintended property of the 1992
formula is obvious in hindsight. Yet this for-
mula has been published at least twice
(16,21) following internal U.S. EPA review
and journal peer review. Why was this prob-
lem not discovered? We believe the explana-
tion lies in the formula being a decision
index. Although the response addition and
relative potency factor methods produce
quantitative estimates of a measurable mix-
ture response, the HI and interaction-based
HI provide only numerical indicators of the
degree of concern for potential mixture toxic-
ity. Consequently, instead of performing the
usual observed versus expected comparison,
such formulas are judged on their plausibility,
an evaluation that can be quite subjective. In
fact, although the U.S. EPA has guidance for
the evaluation of physically based mathemati-
cal models, it presently has no quality assur-
ance process for these kinds of risk-based
decision formulas. We now propose some
general guidance and illustrate the steps with
these two interaction-based HI formulas.
Methods
These two formulas (Equations 2, 6) were
designed from general concepts of interac-
tion, not from extensive data or mechanistic
principles. As discussed before, evaluations of
the quality of such formulas cannot use com-
mon statistical tests and procedures such as
goodness-of-ﬁt calculations. Instead, for such
formulas we recommend simple rules based
on a formula’s structure and its numerical
behavior. First, the formula must reﬂect most
of the basic concepts or principles believed to
apply to the environmental situation being
assessed. Second, the formula must accurately
track the numerical behavior of simpliﬁed or
trivial conditions, i.e., situations where the
correct result is known. Because these formu-
las are simple approximations, it is likely not
all underlying concepts will be reﬂected, and
not all trivial conditions will be accurately
tracked. For component-based mixture assess-
ment, we suggest the following properties for
use in evaluating the mixture formulas.
Basic concepts:
1)If a chemical is not involved in any
toxicologic interactions, then as that chem-
ical’s exposure level increases, the mixture
index formula also increases in magnitude.
This property assumes the chemical has a
monotonically increasing dose–response
curve.
2)The formula must be symmetric for a
chemical pair in that it makes no difference
which chemical is denoted chemical 1.
3)The impact of an interaction on HI
modified to reflect pairwise toxicologic
interactions (HIINT) increases if the
WOE for the interaction increases, all
other factors held constant.
4)The formula must reflect the relative
proportions of the components so the con-
tribution of any pairwise interaction, for
HQ1 + HQ2 ﬁxed, is strongest when the two
chemicals are at equitoxic exposure levels
(i.e., when HQ1 = HQ2). This concept
applies regardless of the strength of evidence
for the interaction.
5)The interaction magnitude is defined in
terms of a change in isoeffective dose (e.g.,
change in the ED10).
Accuracy for trivial cases:
6)If all M values are 1, i.e., if there are no
toxicologic interactions, then the interac-
tion formula must equal the standard HI in
Equation 1 regardless of the value of the
WOE score, B.
7)If all interactions have perfect data for
synergism (Bij = 1 for all chemical pairs)
and all interaction magnitudes (i.e., Mj =
M for all j) are identical, then the stan-
dard HI is increased by at most that factor
M. For example, if all Mj = 5, so all com-
ponent chemicals are equally synergistic,
then HIINT = 5*HI when all chemicals are
at equitoxic levels (from property 4).
8)For any fixed set of exposures (i.e., fixed
HQs), as the WOE diminishes (as B
decreases toward zero), the HIINT will
approach the standard HI in Equation 1.
Results
Basic concepts 1–3 are satisfied by both
formulas, Equations 2 and 6, as is the
consistency with trivial case 8:
1)Let us use chemical 2 as the one not
involved in interactions. The only terms
that can be negative are those involving the
B values. Because chemical 2 has no role in
the interaction terms, all the B2k and Bj2
are zero. The only places that include HQ2
then are in linear functions with positive
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Table 1. WOE classiﬁcation for Equation 6.a
I The interaction has been shown to be relevant to human health effects and the
direction of the interaction is unequivocal.
II The direction of the interaction has been demonstrated in vivo in an appropriate
animal model, and relevance to potential human health effects is likely.
III An interaction in a particular direction is plausible, but the evidence supporting
the interaction and its relevance to human health effects is weak.
IV The information is
a) Insufﬁcient to determine the direction of any potential interaction.
b) Insufﬁcient to determine whether any interaction would occur.
c) Adequate as evidence that no toxicologic interaction between/among the compounds is plausible.
aData from U.S. EPA (3).
Table 2. Scores for the WOE classiﬁcation in Table 1.a
Interaction
Greater than Less than
Category Evidence additive additive
I The interaction has been shown to be relevant to human  1.0 –1.0
health effects and the direction of the interaction is unequivocal.
II The direction of the interaction has been demonstrated in vivo 0.75 –0.50
in an appropriate animal model, and the relevance to potential
human health effects is likely.
III An interaction in a particular direction is plausible, but the  0.50 0.0
evidence supporting the interaction and its relevance to human
health effects is weak.
IV The assumption of additivity has been demonstrated or must be accepted. 0.0 0.0
aData from U.S. EPA (3).coefficients such as HI in Equation 2.
An increase in HQ2 then results in an
increase in either interaction index.
2)Interchanging j with k as indices is easily
seen to result in the same formulas.
3)In Equation 2, UFI > 0, and in Equation 6,
M > 0. Let us use the WOE score, B23.
The B23 value only appears once, and only
in the exponent of each of these constants,
as the argument of a linear function with
positive coefﬁcients. For synergism, as B23
increases toward 1 (all other parameters
constant), then the corresponding interac-
tion terms in each formula (UFI and Mjk)
are raised to larger positive powers and so
increase. As B23 moves toward –1 (antago-
nism), these interaction terms are raised to
decreasing powers, and so will decrease.
8)For Equation 2, as |B| approaches zero, all
terms in WOES approach zero. Because the
number of terms is finite, WOES, and
hence WOEN, approach zero, and thus
Equation 2 approaches HI. For Equation 6,
as |B| decreases to zero, MBg approaches 1,
and thus Equation 6 also approaches HI.
Note that, at the limit, this condition of no
evidence of interaction is conceptually
equivalent to condition 6.
Property 4 is not satisﬁed by Equation 2 but
is by Equation 6:
4)This property says if HQ1 + HQ2 = H, a
fixed value, and HQ1 varies from 0 up to
H, then the interaction factor is maximal
when HQ1 = HQ2. The intent of using the
geometric mean in Equations 4 and 8 is to
ensure the interaction is maximal when the
two components are at equitoxic exposure
levels.
Equation 2 does not satisfy this property, as
shown earlier for the case when all Bjk =1.
This formula, however, also fails for any com-
mon value for the Bjk. With constant HI,
when the WOE scores, {Bjk}, are all equal,
e.g., B, then HIINT, is constant. This is
because B can then be pulled out of the dou-
ble summation in WOES, so the exponent
simpliﬁes to WOEN = B.
[9]
Equation 6 satisfies this property. In the
interaction factor, MBg , the only part
involving the exposures is the function g.
For chemicals 1 and 2, g12 is the geometric
mean of HQ divided by half of (HQ1 +
HQ2), which is ﬁxed at H. So the maximum
of MBg is attained at the maximum of the
geometric mean.
Properties 5, 6, and 7 require a parameter
for M that is present only in Equation 6, so
Equation 2 will not be considered further.
5)In Equation 6, M is deﬁned as in property 5.
6)If all the Mjk = 1, then B plays no role, and
Equation 6 becomes
[10]
7)Let Bjk = 1 for all j,k, and let Mjk = 5 for all
j,k. In addition, let all HQjk = H. Then
from Equation 8, all gjk = 1, and thus all
MBg = 5. From the evaluation above for
condition 6, the sum of the fjk = 1. Thus,
Equation 6 reduces to
[11]
Equation 6 then manifests the desired
properties for all the basic concepts and trivial
cases. Equation 2 fails concept 4.
Discussion
Risk assessment of chemical mixtures in
practice is usually inhibited by the lack of
desirable information. For the dose–response
step of the assessment, the missing data usu-
ally include whole-mixture toxicity data as
well as information on at least some of the
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Table 3. WOE classiﬁcation and score for Equation 2.a,b
Classiﬁcation Factor
Direction of interaction Direction
= Additive 0
> Greater than additive +1
< Less than additive –1
? Indeterminate 0
Quality of the data Weighting
Mechanistic understanding
I Direct and unambiguous mechanistic data: the  1.0
mechanism(s) by which the interactions could occur has been
well characterized and leads to an unambiguous interpretation
of the direction of the interaction.
II Mechanistic data on related compounds: the  0.71
mechanism(s) by which the interactions could occur have not
been well characterized for the chemicals of concern, but
structure–activity relationships, either quantitative or informal,
can be used to infer the likely mechanisms(s) and the direction
of the interaction.
III Inadequate or ambiguous mechanistic data: the  0.32
mechanism(s) by which the interactions could occur has not
been well characterized or information on the mechanism(s)
does not clearly indicate the direction that the interaction will have.
Toxicologic signiﬁcance
A. The toxicologic signiﬁcance of the interaction has been  1.0
directly demonstrated.
B. The toxicologic signiﬁcance of the interaction can be  0.71
inferred or has been demonstrated for related chemicals.
C. The toxicologic signiﬁcance of the interaction is unclear.  0.32
Modiﬁers
1. Anticipated exposure duration and sequence. 1.0
2. Different exposure duration or sequence. 0.79
a. In vivo data 1.0
b. In vitro data 0.79
i. Anticipated route of exposure 1.0
ii. Different route of exposure 0.79
aWeighting factor = product of weighting scores (range = 0.5, 1.00). In Equation 2, B = direction factor × weighting
factor (range = –1.00, 1.00). bData from ATSDR (20).
Figure 1. Comparison of the two interaction HI
formulas for various component proportions
showing the inability of the 1992 formula to reflect
changes in composition. This example fixes HQ1 +
HQ2 = 5, and sets both M1 and M2 = 5.
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ecomponent interactions. To avoid ignoring
the potential for joint toxicity, the U.S. EPA
has developed quantitative decision formulas.
We have shown the plausibility that such for-
mulas cannot be judged on the basis of the
general formula structure or on the numeri-
cal properties of pieces of the formula.
Equation 2 failed to have a property that
appears to be present in the formula’s con-
struction (the use of the geometric mean of
HQj and HQk). Somehow these risk formulas
must be designed so they produce plausible
numerical values. One approach is to require
that each formula adequately describe simple
conditions that are well understood. For
mixtures, we suggest that these simple condi-
tions include the limit as interactions disap-
pear and the limit as the component
chemicals become more similar in their inter-
actions. We also recommend that the formu-
las behave properly under the best of
conditions, such as when the interactions
data are excellent. Last, we recommend that
these formulas have default parameters and
functions so when the desired mixture data
are weak, the defaults can be implemented.
Mixture risk formulas can occasionally be
tested in the standard manner by goodness-of-
fit comparisons over several whole-mixture
data sets of varying composition. We recom-
mend that data for such evaluations be gener-
ated, at least for representative simple mixtures
for each of the major types of environmental
chemicals such as pesticides, volatile organics,
inorganics, petroleum fractions, and other
commonly occurring chemical groups. For
example, U.S. EPA researchers have designed a
set of experiments exploring hepatotoxicty in
female CD-1 mice for the four tri-
halomethanes (THMs), including assays on
each single chemical, all six binary combina-
tions, and eight 4-THM mixture combination
points (22). The experimental design for one
of the six binary combinations is shown in
Figure 2. The doses and mixing ratios were
selected so interaction effects could be investi-
gated at several total dose levels and at different
proportions in the 2-THM mixture. These
data will help quantify the M factor for the
interaction-based HI and can be used with the
eight 4-THM combination points to adjust
other functions and parameters so the binary
information adequately reﬂects the toxicity of
the whole mixture.
Mixture risk assessment formulas should
improve in the near future as more pharma-
cokinetic models are developed and as more
principles of interaction are identified and
related to individual chemical properties. In
practice, the variety of environmental mix-
tures will ensure that most will have some
missing or weak information. As a result, the
HI formulas discussed in this article may be
enhanced by the new information, but likely
will be forced to include several defaults.
Until extensive data on complete mixtures
become available, judgments of the plausibil-
ity of such formulas will continue to be at
least partly subjective. Using a structured
evaluation such as presented here will help
ensure acceptable quantitative behavior of the
risk formulas.
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Figure 2. Binary experimental design for chloro-
form (CHCl3) and bromodichloromethane (BDCM),
showing various proportions for three different
total doses of 0.1, 1, and 3 mmol/kg/day.
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